Human Responses to Candidate Chlamydial Antigens
Human Responses to Candidate Chlamydial Antigens
批准号:
10392973
负责人:
Toni Darville
金额:
$61.35万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-04-30
关键词:
AddressAgeAntibodiesAntibody ResponseAntigensBacteriaBehavioralBloodCD8-Positive T-LymphocytesCellsCervicalChlamydiaChlamydia InfectionsChlamydia trachomatisClinicalClinical ResearchDataDevelopmentDiseaseEctopic PregnancyEndocervixEndometrialEndometriumEnvironmentExhibitsFemaleFemale genitaliaFrequenciesGenitalGenitaliaGoalsHigh Risk WomanHumanImmuneImmune responseImmune systemImmunityImmunobiologyInfectionInfertilityInterferonsKnowledgeLeftLymphoid TissueMapsMediatingMediationMemoryMucous MembraneNatural ImmunityNorth CarolinaOrganParticipantPathogenesisPersonsPhenotypeProteinsProteomicsPublic HealthRegimenResearchResearch Project GrantsResistanceRiskRoleSerologySexual TransmissionSubunit VaccinesSymptomsT cell responseT memory cellT-LymphocyteT-Lymphocyte SubsetsTechniquesTh1 CellsTissuesTranscriptUniversitiesVaccine AntigenVaccine DesignVaccinesWomanchlamydia vaccinechronic pelvic paincohortdeep sequencingdesignexperiencehigh riskimmunogenicitymenmouse modelnovelnovel vaccinespreventprogramsreproductivereproductive tractresponsetime of flight mass spectrometrytranscriptometranscriptome sequencingvaccine developmentvaccine evaluation
中文摘要
沙眼衣原体(CT)是一种性传播细菌。每年感染1亿人。大多数
英文摘要
Chlamydia trachomatis (CT) is a sexually transmitted bacteria. Each year it infects 100 million people. Most
infections do not have any symptoms so infected people are left untreated. In women the consequences of CT
are severe. Approximately, 1 in every 100 untreated CT infections results in infertility. CT infections in women
can also result in ectopic pregnancy and chronic pelvic pain. Despite the great need, no chlamydial vaccine is
currently available. The broader goal of this research program is to accelerate development of a novel
vaccine that prevents CT-associated infertility and other disease. The goal of this research project is to better
understand how our immune system responds to CT replication in the female genital tract (FGT).
The FGT is a unique organ in our body. To effectively function, the FGT actively suppresses immune
responses. The rationale of this research project is that control of CT replication requires effective immune
cells, called T cells, both in the blood and in the female genital tract. Memory T cells can detect and induce
rapid killing of CT-infected cells. Here, we will investigate CT replication and the host T cell response in two
unique female cohorts. In the first cohort called TRAC, women at high risk of CT infection were followed for 12
months. The second cohort, TRAC2, will be established during this project and will similarly follow women with
high risk of CT infection. Detailed clinical and behavioral data will be available from both cohorts enabling
participants to be classified into several groups – CT-resistant, CT-susceptible, CT-infected but controlling
infection, CT-infected with disseminated infection. Critically, immune cells from both blood and the FGT will be
collected from our participants and available for analysis.
To comprehensively examine the role of T cells both in the blood and FGT, in combatting CT infection we will
pursue the following aims:
Aim 1. Establish a comprehensive approach to identify chlamydial antigens that would be most likely to
contribute to anti-chlamydial immunity. Here we will perform the first study to examine expression of CT
proteins in a woman’s female genital tract. Strongly expressed CT proteins are excellent targets for vaccines.
Aim 2. Characterize the protective memory T cell response to CT in the blood of women who exhibit resistance
to CT reinfection. Here, we aim to identify the types and functions of T cells in the blood that provide resistance
against CT.
Aim 3. Compare and characterize infiltrating and resident T cells in the blood and FGT of women who limit
infection to the endocervix with women who experience CT ascension. Here, we will directly examine the
frequency and function of T cells in the FGT of women who whilst CT infected are able to limit bacterial
replication, with women who fail to limit infection and are therefore at risk of CT-associated disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
-
批准号:10392970
-
项目类别:
-
资助金额:$206.37万
-
财政年份:2019
-
负责人:Toni Darville
-
依托单位:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
-
批准号:10392971
-
项目类别:
-
资助金额:$27.94万
-
财政年份:2019
-
负责人:Toni Darville
-
依托单位:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
-
批准号:10615092
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2019
-
负责人:Toni Darville
-
依托单位:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
-
批准号:10392972
-
项目类别:
-
资助金额:$75.81万
-
财政年份:2019
-
负责人:Toni Darville
-
依托单位:
Human Responses to Candidate Chlamydial Antigens
-
批准号:10615096
-
项目类别:
-
资助金额:$98.29万
-
财政年份:2019
-
负责人:Toni Darville
-
依托单位:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
-
批准号:9922862
-
项目类别:
-
资助金额:$220.3万
-
财政年份:2019
-
负责人:Toni Darville
-
依托单位:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
-
批准号:10615091
-
项目类别:
-
资助金额:$201.33万
-
财政年份:2019
-
负责人:Toni Darville
-
依托单位:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
-
批准号:10615094
-
项目类别:
-
资助金额:$17.77万
-
财政年份:2019
-
负责人:Toni Darville
-
依托单位:
Natural Immunity Against Chlamydia trachomatis
-
批准号:9097009
-
项目类别:
-
资助金额:$70.11万
-
财政年份:2015
-
负责人:Toni Darville
-
依托单位:
Identifying Biomarkers and Genetic Risk Factors Predictive of Reproductive Sequel
-
批准号:8265057
-
项目类别:
-
资助金额:$16.72万
-
财政年份:2012
-
负责人:Toni Darville
-
依托单位:
Identifying Biomarkers and Genetic Risk Factors Predictive of Reproductive Sequel
-
批准号:8828856
-
项目类别:
-
资助金额:$7.07万
-
财政年份:2012
-
负责人:Toni Darville
-
依托单位:
Identifying Biomarkers and Genetic Risk Factors Predictive of Reproductive Sequel
-
批准号:8897975
-
项目类别:
-
资助金额:$44.18万
-
财政年份:2012
-
负责人:Toni Darville
-
依托单位:
Identifying Biomarkers and Genetic Risk Factors Predictive of Reproductive Sequel
-
批准号:8890364
-
项目类别:
-
资助金额:$44.73万
-
财政年份:2012
-
负责人:Toni Darville
-
依托单位:
Identifying Biomarkers and Genetic Risk Factors Predictive of Reproductive Sequel
-
批准号:9110929
-
项目类别:
-
资助金额:$44.04万
-
财政年份:2012
-
负责人:Toni Darville
-
依托单位:
Identifying Biomarkers and Genetic Risk Factors Predictive of Reproductive Sequel
-
批准号:8449576
-
项目类别:
-
资助金额:$12.08万
-
财政年份:2012
-
负责人:Toni Darville
-
依托单位:
VACCINE AGAINST CHLAMYDIAL GENITAL TRACT DISEASE
-
批准号:8357358
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2011
-
负责人:Toni Darville
-
依托单位:
The UPMC Sexually Transmitted Infections Cooperative Research Center
-
批准号:8137734
-
项目类别:
-
资助金额:$280.38万
-
财政年份:2009
-
负责人:Toni Darville
-
依托单位:
Role of TLR2 Signaling in Innate and Adaptive Responses to Chlamydiae
-
批准号:7762460
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2009
-
负责人:Toni Darville
-
依托单位:
Administrative Core
-
批准号:7762462
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2009
-
负责人:Toni Darville
-
依托单位:
The UPMC Sexually Transmitted Infections Cooperative Research Center
-
批准号:8529447
-
项目类别:
-
资助金额:$96.71万
-
财政年份:2009
-
负责人:Toni Darville
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: